Journal List > Korean Circ J > v.51(10) > 1147729

Onorato, Popusoi, Pucciarelli, and Tesorio: Persistent Shunting 50 Years after Surgical Patent Ductus Arteriosus Ligation
A 58-year-old woman presented with progressive dyspnea. When she was 8 years old, a surgical ligation of her hypertensive patent ductus arteriosus (PDA) was performed by left lateral thoracotomy in the 4th intercostal space under general anesthesia. On this admission, 2-dimensional transthoracic echocardiography/transesophageal echocardiography (TTE/TEE) color Doppler showed dilated left atrium, mildly hypertrophied left ventricle with an ejection fraction of 58% with impaired relaxation; parasternal short axis and suprasternal views showed an enlarged main pulmonary artery and a mild left-to-right shunt via a distorted PDA. Right heart catheterization demonstrated a systolic pulmonary artery pressure of 35 mmHg and a pulmonary flow/systemic flow of 1.1:1. After heart team discussion, a catheter-based treatment was confirmed. Percutaneous closure was performed under local anesthesia and fluoroscopic guidance. Aortic arch angiograms showed an elongated ductus with constriction on the left pulmonary artery opening (type E according to classification of Krichenko) (Figure 1, Supplementary Video 1).1) A retrograde approach for crossing the residual PDA was chosen. A 4-Fr compatible 6-mm vascular plug system (Cera; Lifetech Scientific, Shenzhen, China) (Figure 2) was selected for implantation and successfully deployed with abolition of residual shunting (Supplementary Videos 2, 3). The patient was discharged without complications the following day. At 1-month follow-up she remained symptom free and TTE did not demonstrate any residual shunt flow.
Purse-string sutures, PDA ligation and clip, double clip application or ligation and division are safe and more effective procedures than PDA ligation only. Actually, recanalization after simple ligation may cause residual shunts, whose reported frequency is not negligible and varies from 6% to 23%.2)3)4)5) In summary, routine transcatheter closure of any residual PDA appears to be the most reasonable choice, given the great feasibility and very low morbidity of this standard of care treatment.
Written informed consent was obtained from the patient.

Notes

Funding: The authors received no financial support for the research, authorship, and/or publication of this article.

Conflict of Interest: The authors have no financial conflicts of interest.

Data Sharing Statement: The data generated in this study is available from the corresponding authors upon reasonable request.

Author Contributions:

  • Conceptualization: Onorato EM.

  • Data curation: Onorato EM.

  • Investigation: Onorato EM.

  • Methodology: Onorato EM.

  • Validation: Onorato EM.

  • Writing - original draft: Onorato EM, Popusoi G, Pucciarelli A, Tesorio T.

  • Writing - review & editing: Onorato EM.

References

1. Krichenko A, Benson LN, Burrows P, Möes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol. 1989; 63:877–880. PMID: 2929450.
crossref
2. Jung JW. Do we have to close residual patent ductus arteriosus after surgery or transcatheter intervention? Korean Circ J. 2011; 41:639–640. PMID: 22194757.
crossref
3. Baspinar O, Kilinc M, Kervancioglu M, Irdem A. Transcatheter closure of a residual patent ductus arteriosus after surgical ligation in children. Korean Circ J. 2011; 41:654–657. PMID: 22194760.
crossref
4. Chuang YC, Yin WH, Hsiung MC, et al. Successful transcatheter closure of a residual patent ductus arteriosus with complex anatomy after surgical ligation using an amplatzer ductal occluder guided by live three-dimensional transesophageal echocardiography. Echocardiography. 2011; 28:E101–E103. PMID: 21395670.
crossref
5. Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis. 2010; 5:354–365. PMID: 20653702.
crossref

SUPPLEMENTARY MATERIALS

Supplementary Video 1

Baseline descending aorta angiogram showing an elongated patent ductus with marked narrowing towards the pulmonary artery side and mild left-to-right shunt.

Supplementary Video 2

Selective angiography via the delivery system with the 6-mm vascular plug still screwed into the pusher.

Supplementary Video 3

Post-procedure aorta angiography showing the correct position of the 6-mm vascular plug with a trace residual shunt immediately after residual patent ductus arteriosus closure.
Figure 1

Fluoro-angiographic procedural steps in latero-lateral projection. (A) Baseline aortic arch angiogram showing an elongated patent ductus (red asterisk) with marked narrowing towards the pulmonary artery side (type E, according to angiographic classification of Krichenko). (B) The 5-Fr delivery system passed retrogradely through the patent ductus arteriosus from the aorta and the 6-mm vascular plug system (Cera; Lifetech Scientific, Shenzhen, China) is being advanced inside it. (C) A selective angiogram through the 5-Fr delivery system confirming the position of the 6-mm vascular plug with a tiny residual shunt. (D) Final aortic arch angiogram showing abolition of the left-to-right shunt and the correct position of the occluding device.

kcj-51-877-g001
Figure 2

The vascular plug system (Cera; Lifetech Scientific, Shenzhen, China) is a self-expandable, cylindrical device coated with proprietary titanium nitride and available in various sizes range. Polytetrafluoroethylene membranes are dense and securely sewn into device to fill up the hole and block blood flow. In particular LT-PLUG-06 is 4-Fr compatible with an unconstrained plug length of 7 mm.

kcj-51-877-g002
TOOLS
Similar articles